Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR)

13 november 2026 uppdaterad av: Edwards Lifesciences

En prospektiv, multicenter, randomiserad, kontrollerad pivotal prövning för att utvärdera säkerheten och effektiviteten av reparation av transkatetertricuspidklaff med Edwards PASCAL Transcatheter Valve Repair System och Optimal Medical Therapy (OMT) jämfört med OMT ensam hos patienter med trikuspidaluppstötningar

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

Studieöversikt

Status

Aktiv, inte rekryterande

Betingelser

Intervention / Behandling

Detaljerad beskrivning

A Prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation. Patients will be seen for follow-up visits at discharge, 30 days, 3 months, 6 months, and annually through 5 years.

Studietyp

Interventionell

Inskrivning (Beräknad)

1270

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Arizona
      • Phoenix, Arizona, Förenta staterna, 85006
        • Banner University Medical Center Phoenix
      • Tucson, Arizona, Förenta staterna, 85712
        • Tucson Medical Center Healthcare
    • California
      • Irvine, California, Förenta staterna, 92868
        • University of California, Irvine
      • La Jolla, California, Förenta staterna, 92037
        • SCPMG - Kaiser San Diego
      • Los Angeles, California, Förenta staterna, 90048
        • Cedars Sinai Medical Center
      • Los Angeles, California, Förenta staterna, 90095
        • UCLA Medical Center
      • San Francisco, California, Förenta staterna, 94143
        • University of California, San Francisco
      • San Francisco, California, Förenta staterna, 94118
        • Kaiser Permanente San Francisco
      • Stanford, California, Förenta staterna, 94305
        • Stanford University
    • Colorado
      • Denver, Colorado, Förenta staterna, 80218
        • St. Joseph Hospital
      • Loveland, Colorado, Förenta staterna, 80538
        • Medical Center of the Rockies
    • Florida
      • Gainesville, Florida, Förenta staterna, 32605
        • The Cardiac and Vascular Institute Research Foundation
      • Miami Beach, Florida, Förenta staterna, 33140
        • Mount Sinai Medical Center
      • Naples, Florida, Förenta staterna, 34102
        • NCH Healthcare System
      • Sarasota, Florida, Förenta staterna, 34239
        • Sarasota Memorial Health Care System
      • Tallahassee, Florida, Förenta staterna, 32308
        • Tallahassee Research Institute
    • Georgia
      • Atlanta, Georgia, Förenta staterna, 30309
        • Piedmont Healthcare, Inc.
      • Atlanta, Georgia, Förenta staterna, 30308
        • Emory University Hospital Midtown / Emory University - St. Joseph's Hospital
    • Illinois
      • Chicago, Illinois, Förenta staterna, 60611
        • Northwestern University
    • Indiana
      • Indianapolis, Indiana, Förenta staterna, 46290
        • Ascension St. Vincent Heart Center Cardiovascular Research Institute
    • Iowa
      • Iowa City, Iowa, Förenta staterna, 52242
        • University of Iowa Hospitals & Clinics
    • Louisiana
      • New Orleans, Louisiana, Förenta staterna, 70121
        • Ochsner Medical Center
    • Maryland
      • Baltimore, Maryland, Förenta staterna, 21287
        • Johns Hopkins
    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02114
        • Massachusetts General Hospital
    • Michigan
      • Ann Arbor, Michigan, Förenta staterna, 48109
        • University of Michigan
      • Detroit, Michigan, Förenta staterna, 48202
        • Henry Ford Hospital
      • Royal Oak, Michigan, Förenta staterna, 48073
        • William Beaumont Hospital - Royal Oak
      • Saginaw, Michigan, Förenta staterna, 48601
        • St. Mary's of Ascension Research
    • Minnesota
      • Maplewood, Minnesota, Förenta staterna, 55109
        • Fairview Health Services
      • Rochester, Minnesota, Förenta staterna, 55905
        • Mayo Clinic
    • Missouri
      • Kansas City, Missouri, Förenta staterna, 64111
        • Saint Luke's Hospital of Kansas City
      • St Louis, Missouri, Förenta staterna, 63110
        • Washington University School of Medicine
    • Montana
      • Missoula, Montana, Förenta staterna, 59802
        • Providence St. Patrick Hospital
    • New Hampshire
      • Lebanon, New Hampshire, Förenta staterna, 03756
        • Dartmouth-Hitchcock Medical Center
    • New Jersey
      • Camden, New Jersey, Förenta staterna, 09103
        • Cooper Health Systems
      • Morristown, New Jersey, Förenta staterna, 07962
        • Morristown Medical Center
      • New Brunswick, New Jersey, Förenta staterna, 08901
        • Rutgers Robert Wood Johnson Medical School
    • New York
      • Buffalo, New York, Förenta staterna, 14203
        • State University of New York at Buffalo
      • New York, New York, Förenta staterna, 10065
        • Weill Cornell Medicine
      • New York, New York, Förenta staterna, 10032
        • Columbia University Irving Medical Center/NYPH
      • New York, New York, Förenta staterna, 10075
        • Lenox Hill Hospital, Northwell Health /Northshore University Hospital Manhasset
      • Rochester, New York, Förenta staterna, 14621
        • Rochester General Hospital
      • Roslyn, New York, Förenta staterna, 11576
        • St. Francis Hospital
      • The Bronx, New York, Förenta staterna, 10467
        • Montefiore Medical Center / Arts Pavilion / Hutchinson Metro Center Clinic / Weiler Hospital / Moses Hospital
    • North Carolina
      • Chapel Hill, North Carolina, Förenta staterna, 27517
        • University of North Carolina
    • North Dakota
      • Fargo, North Dakota, Förenta staterna, 58104
        • Sanford Medical Center Fargo
    • Ohio
      • Cincinnati, Ohio, Förenta staterna, 45219
        • The Christ Hospital
      • Cincinnati, Ohio, Förenta staterna, 45242
        • TriHealth-Bethesda North Hospital
      • Columbus, Ohio, Förenta staterna, 43210
        • The Ohio State University
    • Oklahoma
      • Oklahoma City, Oklahoma, Förenta staterna, 73112
        • Integris Baptist Medical Center
      • Oklahoma City, Oklahoma, Förenta staterna, 73120
        • Oklahoma Cardiovascular Research Group
      • Tulsa, Oklahoma, Förenta staterna, 74104
        • Oklahoma Heart Institute at Hillcrest Medical Center
    • Oregon
      • Portland, Oregon, Förenta staterna, 97239
        • Oregon Health & Science University
    • Pennsylvania
      • Hershey, Pennsylvania, Förenta staterna, 17033
        • Penn State Hershey
      • Philadelphia, Pennsylvania, Förenta staterna, 19104
        • Pennsylvania Presbyterian Medical Center / Hospital of the University of Pennsylvania
      • Wormleysburg, Pennsylvania, Förenta staterna, 17043
        • Pinnacle Health Cardiovascular Institute/UPMC Pinnacle
      • Wynnewood, Pennsylvania, Förenta staterna, 19096
        • Lankenau Heart Institute
    • South Carolina
      • Charleston, South Carolina, Förenta staterna, 29245
        • Medical University of South Carolina
    • Tennessee
      • Chattanooga, Tennessee, Förenta staterna, 37403
        • Erlanger Health System
      • Nashville, Tennessee, Förenta staterna, 37212
        • Vanderbilt University Medical Center
    • Texas
      • Houston, Texas, Förenta staterna, 77030
        • The University of Texas Health Science Center at Houston
      • Houston, Texas, Förenta staterna, 77004
        • HCA Houston Healthcare Medical Center
      • Houston, Texas, Förenta staterna, 77030
        • Baylor College of Medicine St. Luke's Medical Center
      • Houston, Texas, Förenta staterna, 77030
        • UTHealth/Memorial Hermann Hospital
      • Plano, Texas, Förenta staterna, 75093
        • Baylor Scott & White - The Heart Hospital - Plano
    • Utah
      • Murray, Utah, Förenta staterna, 84107
        • Intermountain Medical Center
      • St. George, Utah, Förenta staterna, 84790
        • St. George Regional Hospital
    • Virginia
      • Charlottesville, Virginia, Förenta staterna, 22908
        • University of Virginia Health System
      • Richmond, Virginia, Förenta staterna, 23298
        • Virginia Commonwealth University
      • Roanoke, Virginia, Förenta staterna, 24014
        • Carilion Medical Center
    • Washington
      • Seattle, Washington, Förenta staterna, 98101
        • Virginia Mason Medical Center
      • Seattle, Washington, Förenta staterna, 98122
        • Swedish Medical Center
    • Wisconsin
      • Milwaukee, Wisconsin, Förenta staterna, 53226
        • Medical College of Wisconsin
    • British Columbia
      • Vancouver, British Columbia, Kanada, V6Z 1Y6
        • St. Paul's Hospital
    • Ontario
      • Hamilton, Ontario, Kanada, L8L 2X2
        • Hamilton Health Services
      • Ottawa, Ontario, Kanada, K1Y 4Q7
        • University of Ottawa Heart Institute
      • Toronto, Ontario, Kanada, M4N 3M5
        • Sunnybrook Health Sciences Centre
      • Toronto, Ontario, Kanada, M5B 1W8
        • St. Michael's Hospital
    • Quebec
      • Québec, Quebec, Kanada, G1V 4G5
        • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Eighteen (18) years of age or older
  • Despite medical therapy, per the local Heart Team, patient has signs of TR, symptoms from TR, or prior heart failure hospitalization from TR.
  • Severe or greater tricuspid regurgitation
  • New York Heart Association (NYHA) Class II-IVa or heart failure hospitalization in the prior 12 months
  • Patient is at an intermediate or greater estimated risk of mortality with tricuspid valve surgery as determined by the cardiac surgeon with concurrence by the local Heart Team
  • Patient is able and willing to give informed consent, follow protocol procedures, and comply with follow-up visit requirements

Exclusion Criteria:

  • Tricuspid valve anatomy not evaluable by TTE or TEE

  • Tricuspid valve anatomy precludes proper device deployment and function

  • Patient with refractory heart failure requiring, advanced intervention (i.e. patient has or will need left ventricular assist device, or transplantation) (ACC/AHA Stage D heart failure)

  • Presence of trans-tricuspid pacemaker or defibrillator leads which meet one of the following:

    1. Would prevent proper TR reduction due to interaction of the lead with the leaflets
    2. Were implanted in the RV within the last 90 days prior to the point of enrollment
  • Primary non-degenerative tricuspid disease

  • Previous tricuspid valve repair or replacement that would interfere with placement of PASCAL

  • Clinically significant, untreated coronary artery disease requiring revascularization, unstable angina, evidence of acute coronary syndrome, recent myocardial infarction

  • Significant intra-cardiac mass, thrombus, or vegetation per echo core lab assessment

  • Deep vein thrombosis (DVT) or pulmonary embolism (PE) in the last 90 days

  • Recent Stroke

  • Active gastrointestinal (GI) bleeding

  • Presence of infiltrative cardiomyopathy or valvulopathy (including carcinoid, amyloidosis, sarcoidosis, hemochromatosis) or significant congenital heart disease, including but not limited to atrial septal defect, RV dysplasia, and arrhythmogenic RV

  • Need for emergent or urgent surgery for any reason, any planned cardiac surgery within the next 12 months (365 days), or any planned percutaneous cardiac procedure within the next 90 days

  • Any of the following cardiovascular procedures:

    1. Percutaneous coronary, intracardiac, or endovascular intervention within the last 30 days prior to the point of enrollment
    2. Carotid surgery within 30 days prior to the point of enrollment
    3. Direct current cardioversion within the last 30 days prior to the point of enrollment
    4. Leadless RV pacemaker implant within the last 30 days prior to the point of enrollment
    5. Cardiac surgery within 90 days prior to the point of enrollment
  • Severe aortic, mitral and/or pulmonic valve stenosis and/or regurgitation

  • Known history of untreated severe symptomatic carotid stenosis or asymptomatic carotid stenosis

  • Active endocarditis within the last 90 days or infection requiring antibiotic therapy within the last 14 days

  • Patient is oxygen-dependent or requires continuous home oxygen

  • Pregnant, breastfeeding, or planning pregnancy within the next 12 months (365 days)

  • Concurrent medical condition with a life expectancy of less than 12 months in the judgment of the Investigator

  • Patient is currently participating in another investigational biologic, drug, or device clinical study

  • Patient has other medical, social, or psychological conditions that preclude appropriate consent and follow-up, or the patient is under guardianship

  • Any patient considered to be vulnerable

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Edwards PASCAL System & OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

Andra namn:
  • Reparation av transkateter trikuspidalklaff (TTVr)

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Aktiv komparator: Optimal Medical Therapy (OMT)

Optimal medical therapy (OMT) alone in patients with tricuspid regurgitation

Optimal Medical Therapy alone in patients with tricuspid regurgitation

Experimentell: Single-Arm Registry

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with optimal medical therapy (OMT) in patients with tricuspid regurgitation who are not eligible for randomization

Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

Andra namn:
  • Reparation av transkateter trikuspidalklaff (TTVr)

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Experimentell: Continued Access Study

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

Andra namn:
  • Reparation av transkateter trikuspidalklaff (TTVr)

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Composite endpoint including all-cause mortality, RVAD implantation or heart transplant, tricuspid valve intervention, heart failure hospitalizations, and Quality of Life improvement (measured by KCCQ score)
Tidsram: 6 months

Comparison of number of participants with composite endpoint events between experimental and active comparator arms

6 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
1 Grade Reduction in TR Severity
Tidsram: 6, 12 months

Total number of participants with at least 1 grade reduction in TR severity

6, 12 months
Quality of Life (QOL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Tidsram: 3, 6, and 12 months

Change in KCCQ score from baseline

3, 6, and 12 months
All Cause Mortality
Tidsram: 12 months, 24 months

Total number of deaths from any cause

12 months, 24 months
Death and Heart Failure Hospitalizations
Tidsram: 12 months

Total number of deaths and hospital admissions due to heart failure

12 months
All-cause Mortality, TV Surgery or TV Interventions
Tidsram: 24 months

Total number of deaths, TV surgeries or interventions

24 months
Right ventricular end-diastolic diameter (RVEDD mid)
Tidsram: 12 months

Change in right ventricular end-diastolic diameter (RVEDD mid)

12 months
Major Adverse Events (MAEs)
Tidsram: 30 days

Overall rate of Major Adverse Events (MAEs)

30 days
Reduction in TR grade
Tidsram: Intraprocedural post-implantation

Reduction in TR severity as assessed by TEE pre- and post-implantation

Intraprocedural post-implantation
All-Cause Mortality
Tidsram: 12 months, annually through 5 years

Total number of deaths from any cause

12 months, annually through 5 years
Heart failure hospitalizations
Tidsram: 12 months, annually through 5 years

Total number of hospital admissions due to heart failure

12 months, annually through 5 years
Non-elective tricuspid valve re-intervenitions (percutaneous or surgical)
Tidsram: 12 months, annually through 5 years

Total number of non-elective tricuspid valve re-interventions

12 months, annually through 5 years
Durable RVAD implantation or heart transplant
Tidsram: 12 months, annually through 5 years

Total number of patients requiring RVAD impantantion or heart transplant

12 months, annually through 5 years
Need for paracentesis
Tidsram: 12 months, annually through 5 years

Total nunber of patients who required paracentesis

12 months, annually through 5 years
All cause mortality or the first heart failure hospitalization for patients with massive or torrential TR at baseline
Tidsram: 12, 24 months

Time to death or first heart failure hospitalization

12, 24 months
All-cause Hospitalizations
Tidsram: 12 months

Number of hospitalizations for any cause

12 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Utredare

  • Huvudutredare: Martin B. Leon, MD, Columbia University
  • Huvudutredare: Michael J. Mack, MD, Baylor Scott and White Health
  • Studiestol: Gorav Ailawadi, MD, University of Michigan
  • Huvudutredare: Charles Davidson, MD, Northwestern University
  • Studiestol: Allen Anderson, MD, The University of Texas Health Science Center at San Antonio

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

11 december 2019

Primärt slutförande (Beräknad)

31 december 2027

Avslutad studie (Beräknad)

31 december 2031

Studieregistreringsdatum

Först inskickad

18 september 2019

Först inskickad som uppfyllde QC-kriterierna

18 september 2019

Första postat (Faktisk)

20 september 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

16 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

13 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 2019-07

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Ja

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .